companydata.dkcompanydata.dk

Initiator Pharma A/S: Financial statements 2020

CVR: 37663808

Source: annual report 2020, Danish Business Authority

01/01/2020 – 31/12/2020

Initiator Pharma A/S (CVR 37663808) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -9,299,000 and a net result of DKK -8,697,000 compared with DKK -8,288,000 the year before. Equity in the 2020 report amounted to DKK 14,409,000. The solvency ratio was 92.3%. The company had 1 employee in the financial year.

Gross Profit
DKK -9,299,000
Profit/Loss
DKK -8,697,000
Equity
DKK 14,409,000
Total Assets
DKK 15,603,000
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2020--9.3M-8.7M14.4M1
2019--8.4M-8.3M9.9M1
2018--11.4M-10.3M16.6M1
2017--8.2M-8.6M6M2

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Initiator Pharma A/S?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2020

Initiator Pharma A/S: The 2019 annual report is outMay 31, 2020

Initiator Pharma A/S has published its annual report for 2019. Gross profit came to DKK -8,366,000, and the net result was DKK -8,288,000.

About Initiator Pharma A/S

Initiator Pharma A/S is a Danish company of the type Aktieselskab based in København N, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Claus Elsborg Olesen. The board consists of Gunnar Magnus Severus Modée Persson (chair), Annette Ingegerd Marie Colin, Claus Elsborg Olesen and Majken Christina Östberg Lloyd. The company is owned by Linc AB and Adrigo Asset Management. The company has 3 employees (2026). In 2025, the company reported a gross profit of DKK -14,828,000 and a net result of DKK -13,687,000 compared with DKK -12,932,000 the year before. Equity in the 2025 report amounted to DKK 29,546,000.

Source: annual report 2025, Danish Business Authority